Trial intelligence / Profile preview

Parenteral Hydroxyurea: A Modulator in Pancreatic Cancer

NCT00019474Phase 2Completed

Sponsor
Montefiore Medical Center
Start
Mar 1998
Primary completion
Aug 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hydroxyurea in gastrointestinal cancer, sponsored by Montefiore Medical Center. Started Mar 1998; status: completed.

02

Drugs

hydroxyurea
03

Conditions

gastrointestinal cancer

Beyond the preview

Go deeper on NCT00019474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00019474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call